MCM
ANVS icon

MAI Capital Management’s Annovis Bio ANVS Stock Holding History

MAI Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11K Buy
+500
New +$1.37K ﹤0.01% 4140

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

MAI Capital Management's ANVS Position: Q1 2026 in Review

MAI Capital Management opened a new position in Annovis Bio (ANVS) in Q1 2026: 500 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #4140 among its holdings.

56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • MAI Capital Management held 500 shares of Annovis Bio worth $1.11K as of Q1 2026.
  • Annovis Bio was a new MAI Capital Management position in Q1 2026.
  • Annovis Bio made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4140 holding.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.